Angiographic pattern of in-stent restenosis (ISR) after drug-eluting stent (DES) implantation different to that after bare metal stent (BMS), but their sub...Angiographic pattern of in-stent restenosis (ISR) after drug-eluting stent (DES) implantation different to that after bare metal stent (BMS), but their subsequent TLR rate was similar to both types of DES.
to medicine ISR coronary interventional stent cardiology BMS restenosis angiography bare-metal angiogram cardiovascular occlusion disease DES stents drug-eluting artery by avivagabriel on Jul 27, 2007, 6:46 PM- to coronary cardiology genous healing wounds stenting delayed syndrome medicine vascular atherosclerosis cardiovascular occlusion drug-eluting plaque artery restenosis DES late injury stents disease by avivagabriel on Jul 15, 2007, 7:09 PM
An investigational drug-eluting stent called Xience, coated with everolimus, led to significantly less late lumen loss after nine months than did the Taxus...An investigational drug-eluting stent called Xience, coated with everolimus, led to significantly less late lumen loss after nine months than did the Taxus (paclitaxel-eluting) stent, said researchers here today. March 2007
to clinical stone stents loss disease medicine drug-eluting SPIRIT-III trials occlusion restenosis taxus everolimus cardiovascular lumen late-stage clinical_trials plaque syndrome NYC xience stenting coronary artery paclitaxel late cardiology atherosclerosis by avivagabriel on Jul 15, 2007, 6:20 PMAn investigational bioabsorbable coronary artery stent, in its first human trials, showed acceptable safety, with efficacy better than bare-metal devices b...An investigational bioabsorbable coronary artery stent, in its first human trials, showed acceptable safety, with efficacy better than bare-metal devices but well short of drug-eluting devices, Dutch researchers said here.
to safety DES stents restenosis BMS stenting bare-metal syndrome bioabsorbable drug-eluting everolimus medicine artery cardiology plaque magnesium cardiovascular coronary atherosclerosis disease efficacy occlusion by avivagabriel on Jul 15, 2007, 6:12 PM- to artery sirolimus syndrome reviews late-stage cypher meta-analysis plavix BASKET medicine clopidrogel atherosclerosis restenosis plaque cardiology meta-reviews coronary disease trials mortality taxus drug-eluting paclitaxel clinical clinical_trials RAVEL DES occlusion cardiovascular by avivagabriel on Jul 15, 2007, 4:53 PM
- to clots late coronary cardiology platelets disease clotting occlusion medicine DES BMS mortality syndrome expensive bare cardiovascular atherosclerosis antiplatelets metal plaque endothelium endothelial restenosis artery plavix by avivagabriel on Jul 15, 2007, 4:48 PM
- to stents cardiology drug-eluting restenosis interventional stenting studies drug-coated trials cardiologists late research plavix by avivagabriel on Jul 15, 2007, 7:04 AM
FDA says drug-eluting stents are safe & effective in stable patients with single-vessel disease; even so, they'll have to take Plavix (clopidogrel) & aspir...FDA says drug-eluting stents are safe & effective in stable patients with single-vessel disease; even so, they'll have to take Plavix (clopidogrel) & aspirin for a year or more...up to a lifetime. High-risk patients with multivessel disease are much more
to risk controversy clopidogrel aspirin uncertainty debate ambiguity disease safety DES restenosis efficacy stents coronary BMS CAD artery thrombosis drug-eluting single-vessel multi-vessel plavix bare-metal by avivagabriel on Jul 14, 2007, 7:50 AMTechniques for penetrating chronic total occlusion (CTO) to ensure complete revascularization using percutaneous coronary techniques. Success is only 50–75...Techniques for penetrating chronic total occlusion (CTO) to ensure complete revascularization using percutaneous coronary techniques. Success is only 50–75%, even in the best hands. How to improve?
to angiograms occlusions angioplasty techniques cardiologists chronic total revascularization angiography guidewires IVUS catheterization catheters cardiac interventional CTO cardiology restenosis by avivagabriel on Jul 12, 2007, 5:18 AMArticles on the various questions, problems, and controversies currently plaguing drug-eluting stents: deployment techniques, stent qualities, antiplatelet...Articles on the various questions, problems, and controversies currently plaguing drug-eluting stents: deployment techniques, stent qualities, antiplatelet therapies, and etiologies of post-DES thrombosis and restenosis.
to cardiologists interventional thrombosis antiplatelet DES drug-eluting catheterization stents cardiology restenosis cardiac techniques research drugs updates controversies deployment by avivagabriel on Jul 12, 2007, 5:08 AMWe must optimize stent deployment & maintain a registry of how well (or poorly) we use drug-eluting stents. Instead of asking “Which stent?” or “How much ...We must optimize stent deployment & maintain a registry of how well (or poorly) we use drug-eluting stents. Instead of asking “Which stent?” or “How much anti-platelet therapy?” we must ask “How effectively are we deploying our stents?”
to methods stiffening bare-metal BMS DES drugs artery angiography angiogram infarction polymerization vessel thrombogenicity restenosis TAXUS deformation compliant endothelialization techniques thrombosis anti-platelet drug-eluting deployment non-compliant direct endpoints abbott incomplete intravascular aspirin coronary polymer myocardial unapposed stenting stents cardiology lesions boston_scientifics MI thienopyridine antiplatelet total IVUS ultrasound balloons occlusion IIb/IIIa apposition struts johnson_&_johnson receptors ischemia ST-elevation guidant quality vasculature interventional cardiologists semi-compliant directly-stented angioplasty deployed platelet SIRIUS clopidogrel occlusions by avivagabriel on Jul 12, 2007, 4:51 AM
::
avivagabriel ::
